Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Lin Xu

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Cancer Management and Research|December 12, 2019
Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host DiseaseQing Ya Wang, Yuan Li, Ze Yin Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia]Yuan Li, Bing-Jie Wang, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 31, 2008
[Clinical contrasting study on hematopoietic stem cell transplantation from HLA-identical sibling and partially HLA-mismatched related donors]Li-Hong Wang, Han-Yun Ren, Yuan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2008
[Clinical study of double units unrelated cord blood transplantation in adult patients with hematological malignancies]Yue Yin, Han-Yun Ren, Xi-Nan Cen, et al.
Cancer Management and Research|December 14, 2020
Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival OutcomesZheng-Yang Song, Han-Yun Ren, Yu-Jun Dong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 15, 2007
[rhIL-11 accelerates the engraftment of platelets after unrelated cord blood transplantation]Mang-ju Wang, Han-yun Ren, Xi-nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 25, 2009
[Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation]Ting Zhou, Xi-Nan Cen, Zhi-Xiang Qiu, et al.
Chinese Medical Journal|September 22, 2011
Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood unitsYue Yin, Han-Yun Ren, Xin-An Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Application of SPECT/PET in patients with lymphoma and its significance in monitoring relapse]Hui Yao, Xi-Nan Cen, Jin-Ping Ou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 8, 2026
[Prognostic Value of Dynamic Monitoring of <i>WT1</i> Expression Levels for Relapse and Overall Survival in AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation During First Complete Remission]Xiao-Ya He, Han-Yun Ren, Yu-Jun Dong, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancer Management and Research|December 12, 2019
Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host DiseaseQing Ya Wang, Yuan Li, Ze Yin Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia]Yuan Li, Bing-Jie Wang, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 31, 2008
[Clinical contrasting study on hematopoietic stem cell transplantation from HLA-identical sibling and partially HLA-mismatched related donors]Li-Hong Wang, Han-Yun Ren, Yuan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2008
[Clinical study of double units unrelated cord blood transplantation in adult patients with hematological malignancies]Yue Yin, Han-Yun Ren, Xi-Nan Cen, et al.
Cancer Management and Research|December 14, 2020
Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival OutcomesZheng-Yang Song, Han-Yun Ren, Yu-Jun Dong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 15, 2007
[rhIL-11 accelerates the engraftment of platelets after unrelated cord blood transplantation]Mang-ju Wang, Han-yun Ren, Xi-nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 25, 2009
[Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation]Ting Zhou, Xi-Nan Cen, Zhi-Xiang Qiu, et al.
Chinese Medical Journal|September 22, 2011
Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood unitsYue Yin, Han-Yun Ren, Xin-An Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Application of SPECT/PET in patients with lymphoma and its significance in monitoring relapse]Hui Yao, Xi-Nan Cen, Jin-Ping Ou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 8, 2026
[Prognostic Value of Dynamic Monitoring of <i>WT1</i> Expression Levels for Relapse and Overall Survival in AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation During First Complete Remission]Xiao-Ya He, Han-Yun Ren, Yu-Jun Dong, et al.
Pageof 5